Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion.
The most severe complication of ovarian hyperstimulation syndrome (OHSS) is thromboembolism, which is related to hemoconcentration. Dextran 40 infusion has greater effectiveness for the treatment of hemoconcentration due to OHSS than does human albumin infusion.
Endo
Toshiaki
T
Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Japan. endot@sapmed.ac.jp
Kitajima
Yoshimitsu
Y
Hayashi
Takuhiro
T
Fujii
Miho
M
Hata
Hiroshi
H
Azumaguchi
Atsushi
A
D000328:Adult; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000097:blood* / Q000188:drug therapy*; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012709:Serum Albumin / Q000627:therapeutic use*
D003911:Dextrans; D010952:Plasma Substitutes; D012709:Serum Albumin